SCHEDULE 13G/A: BlackRock Discloses 4.9% Passive Stake in HCA Healthcare
Beneficial Ownership Report
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a 4.9% beneficial ownership stake in HCA Healthcare, Inc. as of March 31, 2025.
Summary
- BlackRock, Inc. filed an Amendment No. 3 to Schedule 13G regarding its beneficial ownership in HCA Healthcare, Inc.
- As of March 31, 2025, BlackRock beneficially owns an aggregate of 12,133,287 shares of HCA Healthcare, Inc. common stock.
- This represents 4.9% of the total outstanding common stock of HCA Healthcare, Inc.
- BlackRock holds sole voting power over 10,853,609 shares and sole dispositive power over 12,133,287 shares.
- The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual, routine regulatory filing (Schedule 13G) reporting beneficial ownership. It contains no subjective language or forward-looking statements that would indicate a positive or negative sentiment beyond the neutral act of disclosure.
Positives
- BlackRock, a major institutional investor, maintains a significant passive stake in HCA Healthcare, indicating continued confidence in the company as an investment.
- The filing confirms BlackRock's investment is for ordinary course of business, not for control, which suggests stability in the ownership structure and no immediate activist intent.
Negatives
- The reported beneficial ownership of 4.9% is below the 5% threshold that would trigger a Schedule 13D filing, meaning BlackRock is not signaling an active intent to influence or control the issuer's management or strategy.
Risks
- The document itself does not detail risks related to HCA Healthcare's operations. The nature of this filing (Schedule 13G) indicates a passive investment, meaning BlackRock does not intend to influence or control the issuer, which could be seen as a lack of active oversight from a major shareholder.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding HCA Healthcare's future performance or BlackRock's future investment intentions beyond the passive nature of the current holding.
Industry Context
This filing is a routine disclosure by a large institutional asset manager, BlackRock, regarding its passive investment in a major healthcare provider, HCA Healthcare. Such filings are common for large funds managing diversified portfolios and reflect their holdings in publicly traded companies within the healthcare sector, providing transparency on significant ownership stakes.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake, which can offer some stability signal regarding the company's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney date, which was expressly revoked by the new Power of Attorney. |
| 2025-01-21 | Date of execution of the new Power of Attorney by BlackRock, Inc. |
| 2025-03-31 | Date of event which requires filing of this statement (snapshot date for beneficial ownership). |
| 2025-04-25 | Date of filing/signature of the Schedule 13G Amendment No. 3. |
Keywords
BlackRock, HCA Healthcare, Schedule 13G, beneficial ownership, common stock, institutional investment, passive stake, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.